Keyphrases
Denmark
100%
Type 2 Diabetes Mellitus (T2DM)
75%
COVID-19
54%
Observational Cohort Study
32%
Lipids
30%
Risk Factors
29%
Odds Ratio
29%
Healthcare Workers
29%
Randomized Clinical Trial
28%
Preeclampsia
28%
Microbiome
26%
Placebo
24%
Metformin
23%
Copenhagen
23%
Gut Microbiome
22%
Genome-wide Association Study
21%
Lolland-Falster Health Study
21%
Urinary Incontinence
21%
Gut Microbiota
21%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
20%
Weight Loss
20%
First Trimester
20%
Confidence Interval
19%
Ceramide
19%
DANBIO Registry
19%
European Ancestry
19%
Quality of Life
19%
Women with Diabetes
19%
Non-small Cell Lung Cancer (NSCLC)
19%
Nationwide Observational Study
19%
Cardiometabolic Disease
19%
Programmed Death-ligand 1 (PD-L1)
19%
Diabetes
18%
Without Diabetes
18%
Type 2 Diabetic Patients
18%
Hemoglobin A1c (HbA1c)
17%
Lipid Levels
17%
Insulin Sensitivity
16%
Disease Activity
16%
Meta-analysis
16%
Nave
15%
Patients with COVID-19
15%
After Surgery
15%
Body Mass Index
15%
Insulin
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Tumor Cells
14%
Prospective Cohort Study
13%
Serum Metabolomics
13%
Type I Diabetes
12%
Oral Glucose Tolerance Test
12%
Adjuvant Chemotherapy
12%
Glycated Hemoglobin
12%
Insulin Therapy
12%
Randomized Placebo-controlled Trial
12%
Reinfection
12%
Disease Severity
12%
Insulin Dose
12%
Blood Lipids
12%
Multi-ancestry
12%
Metabolomics
12%
Seroprevalence
12%
Immune Cells
11%
Omics
11%
Risk Reduction
11%
Resource Use
11%
Clinical Outcomes
11%
Viral
11%
Infections In Pregnancy
11%
Risk Markers
11%
Maternal Serum
11%
Blood Lipid Profile
11%
Cardiovascular Risk
11%
Pregnancy Outcome
10%
Metformin Therapy
10%
Randomized Controlled Trial
10%
Outpatient Clinic
10%
Health Studies
10%
National Cohort Study
10%
Microbiota
10%
Genome Analysis
10%
Fetal Growth
10%
Genetic Variants
10%
DNA Oxidation
9%
Once-weekly
9%
Cardiovascular Events
9%
Glycaemic Deterioration
9%
Dialysis
9%
Serum Adiponectin
9%
Gene Pleiotropy
9%
Heart Failure
9%
Tumour Necrosis Factor Inhibitor (TNFi)
9%
Ankylosing Spondylitis
9%
Chronic Obstructive Pulmonary Disease Treatment
9%
Non-radiographic Axial Spondyloarthritis
9%
Diabetes Research
9%
Operating Room
9%
Wake-up
9%
Schnitzler Syndrome
9%
Oral Anticoagulation
9%
Medicine and Dentistry
Diabetes
33%
Severe Acute Respiratory Syndrome Coronavirus 2
31%
Cohort Analysis
29%
Maturity Onset Diabetes of the Young
27%
Body Mass Index
25%
COVID-19
25%
Infection
23%
First Trimester Pregnancy
23%
Pre-Eclampsia
22%
Combination Therapy
21%
Observational Study
20%
Tamsulosin
19%
Glycon
19%
Quality of Life
19%
Obesity
18%
Odds Ratio
18%
Gut Microbiome
14%
Medicine
13%
Patient with Type 2 Diabetes
13%
Spondylarthritis
13%
Placebo
12%
Maternal Serum
12%
Fetus Growth
11%
Cohort Study
10%
Heart Failure
10%
Deterioration
10%
Urine Incontinence
10%
Diagnosis
10%
Randomized Controlled Trial
10%
Insulin Sensitivity
10%
Oral Glucose Tolerance Test
9%
Hip
9%
Genetic Marker
9%
Oxygen Saturation
9%
Trimethylamine
9%
TNF Inhibitor
9%
Ankylosing Spondylitis
9%
Schnitzler Syndrome
9%
Clinical Trial
9%
Programmed Cell Death
9%
Atrial Fibrillation
9%
Vitamin K Antagonist
9%
Glycated Hemoglobin
9%
Programmed Death-Ligand 1
9%
Anticoagulation
9%
Abdominal Obesity
9%
Non Small Cell Lung Cancer
9%
Operating Room
9%
Glycemic
9%
Kidney Function
9%
Chronic Obstructive Pulmonary Disease
9%
Rheumatic Disease
9%
Adiponectin
9%
Health Care
9%
Prevalence
9%
Intensive Care Unit
9%
Warfarin
9%
Treatment of Lung Cancer
9%
Urodynamics
9%
HLA-B27
9%
Disease Severity
9%
Imidazole
9%
Surgeon
9%
Ingestion
9%
Patient Satisfaction
9%
Gastric Bypass Surgery
9%
Allele
9%
Meal
9%
Sternum
9%
Impaired Glucose Tolerance
9%
Weight Management
9%
Leptin
9%
Propionic Acid
9%
Urinary System
9%
Cardiovascular System
9%
Head and Neck Cancer
9%
Infliximab
9%
Glucose Metabolism
9%
Biosimilar
9%
Hypoxemia
9%
Metalloproteinase
9%
Intensive Care
9%
Nuchal Translucency Measurement
9%
Gut Microbiota
9%
Cognitive Defect
9%
Disintegrin
9%
Metabolite
9%
Apoplexy
8%
Genetic Risk
8%
Gut
8%
Lung Cancer
8%
Photoelectric Plethysmography
7%
Disease Activity
7%
Gestational Age
7%
Drug Therapy
7%
Multiple of the Median
6%
Hemoglobin A1c
6%
Hazard Ratio
6%
Metastatic Carcinoma
6%
Tumor Cell
6%